Target Price | $3.34 |
Price | $0.63 |
Potential |
431.17%
register free of charge
|
Number of Estimates | 3 |
3 Analysts have issued a price target VolitionRX 2025 .
The average VolitionRX target price is $3.34.
This is
431.17%
register free of charge
$5.00
695.17%
register free of charge
$2.00
218.07%
register free of charge
|
|
A rating was issued by 3 analysts: 2 Analysts recommend VolitionRX to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the VolitionRX stock has an average upside potential 2025 of
431.17%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 0.78 | 1.46 |
151.61% | 86.79% | |
Net Margin | -5,922.44% | -1,986.88% |
63.87% | 66.45% |
4 Analysts have issued a sales forecast VolitionRX 2024 . The average VolitionRX sales estimate is
This results in the following potential growth metrics:
3 VolitionRX Analysts have issued a net profit forecast 2024. The average VolitionRX net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -0.50 | -0.31 |
9.09% | 38.00% | |
P/E | negative | |
EV/Sales | 40.05 |
3 Analysts have issued a VolitionRX forecast for earnings per share. The average VolitionRX <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the VolitionRX stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.